Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sylvain Mareschal

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
Bioinformatics (Oxford, England)|April 23, 2014
Rgb: a scriptable genome browser for RSylvain Mareschal, Sydney Dubois, Thierry Lecroq, et al.
Haematologica|August 24, 2011
The proportion of activated B-cell like subtype among de novo diffuse large B-cell lymphoma increases with ageSylvain Mareschal, Hélène Lanic, Philippe Ruminy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 3, 2016
Molecular Profile and FDG-PET Metabolic Volume at Staging in DLBCL-ResponseAnne-Ségolène Cottereau, Hélène Lanic, Sylvain Mareschal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 4, 2016
Molecular Profile and FDG-PET/CT Total Metabolic Tumor Volume Improve Risk Classification at Diagnosis for Patients with Diffuse Large B-Cell LymphomaAnne-Ségolène Cottereau, Hélène Lanic, Sylvain Mareschal, et al.
Genes, Chromosomes & Cancer|May 24, 2012
Several mechanisms lead to the inactivation of the CDKN2A (P16), P14ARF, or CDKN2B (P15) genes in the GCB and ABC molecular DLBCL subtypesSuzan Guney, Fabrice Jardin, Philippe Bertrand, et al.
British Journal of Haematology|April 21, 2015
Outcome of patients older than 60 years with classical Hodgkin lymphoma treated with front line ABVD chemotherapy: frequent pulmonary events suggest limiting the use of bleomycin in the elderlyAspasia Stamatoullas, Pauline Brice, Reda Bouabdallah, et al.
Blood Cancer Journal|June 13, 2020
Integrated transcriptomic and genomic analysis improves prediction of complete remission and survival in elderly patients with acute myeloid leukemiaAlbin Österroos, My Björklund, Anna Eriksson, et al.
Leukemia & Lymphoma|August 19, 2014
Activating somatic mutations in diffuse large B-cell lymphomas: lessons from next generation sequencing and key elements in the precision medicine eraElodie Bohers, Sylvain Mareschal, Philippe Bertrand, et al.
Bioinformatics (Oxford, England)|May 21, 2026
Detecting unannotated splicing events in short-read RNA-seq with SAMI, a UMI-aware Nextflow pipelineSylvain Mareschal, Valentin Wucher, Sarah Huet, et al.
Leukemia & Lymphoma|June 21, 2013
Sarcopenia is an independent prognostic factor in elderly patients with diffuse large B-cell lymphoma treated with immunochemotherapyHélène Lanic, Jerôme Kraut-Tauzia, Romain Modzelewski, et al.
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
Bioinformatics (Oxford, England)|April 23, 2014
Rgb: a scriptable genome browser for RSylvain Mareschal, Sydney Dubois, Thierry Lecroq, et al.
Haematologica|August 24, 2011
The proportion of activated B-cell like subtype among de novo diffuse large B-cell lymphoma increases with ageSylvain Mareschal, Hélène Lanic, Philippe Ruminy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 3, 2016
Molecular Profile and FDG-PET Metabolic Volume at Staging in DLBCL-ResponseAnne-Ségolène Cottereau, Hélène Lanic, Sylvain Mareschal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 4, 2016
Molecular Profile and FDG-PET/CT Total Metabolic Tumor Volume Improve Risk Classification at Diagnosis for Patients with Diffuse Large B-Cell LymphomaAnne-Ségolène Cottereau, Hélène Lanic, Sylvain Mareschal, et al.
Genes, Chromosomes & Cancer|May 24, 2012
Several mechanisms lead to the inactivation of the CDKN2A (P16), P14ARF, or CDKN2B (P15) genes in the GCB and ABC molecular DLBCL subtypesSuzan Guney, Fabrice Jardin, Philippe Bertrand, et al.
British Journal of Haematology|April 21, 2015
Outcome of patients older than 60 years with classical Hodgkin lymphoma treated with front line ABVD chemotherapy: frequent pulmonary events suggest limiting the use of bleomycin in the elderlyAspasia Stamatoullas, Pauline Brice, Reda Bouabdallah, et al.
Blood Cancer Journal|June 13, 2020
Integrated transcriptomic and genomic analysis improves prediction of complete remission and survival in elderly patients with acute myeloid leukemiaAlbin Österroos, My Björklund, Anna Eriksson, et al.
Leukemia & Lymphoma|August 19, 2014
Activating somatic mutations in diffuse large B-cell lymphomas: lessons from next generation sequencing and key elements in the precision medicine eraElodie Bohers, Sylvain Mareschal, Philippe Bertrand, et al.
Bioinformatics (Oxford, England)|May 21, 2026
Detecting unannotated splicing events in short-read RNA-seq with SAMI, a UMI-aware Nextflow pipelineSylvain Mareschal, Valentin Wucher, Sarah Huet, et al.
Leukemia & Lymphoma|June 21, 2013
Sarcopenia is an independent prognostic factor in elderly patients with diffuse large B-cell lymphoma treated with immunochemotherapyHélène Lanic, Jerôme Kraut-Tauzia, Romain Modzelewski, et al.
Pageof 4